Maryam Sahi Affinity Proteomics-Stockholm Unit, SciLifeLab, Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH) KTH Royal Institute of Technology Biography Publications Institution JoVE Articles Maryam Sahi has not added a biography. If you are Maryam Sahi and would like to personalize this page please email our Author Liaison for assistance. Publications Influence of Membrane Phase on the Optical Properties of DPH Molecules (Basel, Switzerland). Sep, 2020 | Pubmed ID: 32957614 Author Spotlight: Advancing Antiviral Strategies through Novel Immunocapture and Mass Spectrometry Techniques Maryam Sahi1, Sarah Andersson1, Cecilia Mattson1, Matilda Dale1, Sofia Kagiolglou1, Camilla Hofström2, Helena Persson2, Jonas Klingström3,4, Francesca Chiodi5, Claudia Fredolini1 1Affinity Proteomics-Stockholm Unit, SciLifeLab, Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 2Human Antibody Therapeutics Unit, SciLifeLab, Division of Drug Discovery and Development, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 3Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 4Public Health Agency of Sweden, 5Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet JoVE 66230 Imunologia e Infecção
Author Spotlight: Advancing Antiviral Strategies through Novel Immunocapture and Mass Spectrometry Techniques Maryam Sahi1, Sarah Andersson1, Cecilia Mattson1, Matilda Dale1, Sofia Kagiolglou1, Camilla Hofström2, Helena Persson2, Jonas Klingström3,4, Francesca Chiodi5, Claudia Fredolini1 1Affinity Proteomics-Stockholm Unit, SciLifeLab, Division of Affinity Proteomics, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 2Human Antibody Therapeutics Unit, SciLifeLab, Division of Drug Discovery and Development, Department of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, 3Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, 4Public Health Agency of Sweden, 5Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet JoVE 66230 Imunologia e Infecção